Suven Life Sciences (SUVEN) — Announcement

📢 Key Event
Suven completes global Phase-3 enrollment for Masupirdine in Alzheimer's agitation

🔄 What Changed
Enrollment exceeded target of 375 patients with 424 randomized; LPLV set for December 2026; topline results due May 2027

🔮 What's Next
Topline results expected by May 2027; Database lock targeted by end of March 2027

💡 Investor Takeaway
This enrollment completion validates Masupirdine's clinical progress and brings definitive efficacy data closer to potential market impact for Alzheimer's agitation treatment.

Suven Life Sciences announced completion of patient enrollment in its global Phase-3 Masupirdine trial for Alzheimer's agitation, exceeding enrollment targets with 424 patients randomized across USA and Europe sites. The study met its primary design of 375 patients but enrolled additional eligible subjects, with last patient visit expected by December 2026 and topline results projected for May 2027. This milestone validates the trial's progress toward definitive efficacy data that could establish Masupirdine as a differentiated therapy addressing significant unmet needs in Alzheimer's-related agitation management.

📄 View Original Announcement (PDF)

📊 Stock Analysis — SUVEN ✨ Ask AI About This

About Suven Life Sciences Ltd (SUVEN)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹9,509.65 Cr ROE: -80.9% ROCE: -80.7%

View full SUVEN stock details →

📡 Get AI alerts when SUVEN files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track SUVEN — Free

💡 Ask AI about this filing

"When will topline results for Masupirdine Phase-3 be announced?" "What regulatory pathway will Masupirdine pursue after Phase-3 completion?" "How does 424-patient enrollment compare to typical Phase-3 trial sizes for similar indications?"

Ask AI Free →

📊 More SUVEN filings

See all SUVEN filings →

🔥 Also filed on 3 September 2026

517554 NHC Foods Ltd Annual Report HINDCOMPOS Hindustan Composites Ltd Announcement 534796 JUJHAR LOGISTICS LIMITED Annual Report 500388 Shree Krishna Paper Mills & Industries Ltd Annual Report VSTL Vibhor Steel Tubes Ltd Insider Trading GAUDIUMIVF Gaudium IVF and Women Health Ltd Annual Report

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when SUVEN files new disclosures

Track SUVEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track SUVEN — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd